• San Diego's Halozyme laying off 160 after dropping experimental cancer drug

    9 days ago - By San Diego Biotechnology

    San Diego biotech will focus on its profitable drug injection technology...
    Read more ...

     

  • Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3

    Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3

    9 days ago - By Xconomy

    An experimental Halozyme Therapeutics treatment for pancreatic cancer has failed a pivotal study, and the company is stopping further development of the drug and closing its oncology operations as part of a corporate restructuring. Halozyme announced Monday that its drug, PEGPH20, did not meet a Phase 3 study's main goal of improving how long patients lived. The San Diego-based company had been testing its drug in combination with gemcitabine and nab-paclitaxel, a pair of chemotherapies regarded as standard treatment for pancreatic cancer. The median overall survival in the group receiving...
    Read more ...